Inventor · disambiguated record
Christoph Martin Dehnhardt
Also filed as: DEHNHARDT CHRISTOPH · DEHNHARDT CHRISTOPH M · DEHNHARDT CHRISTOPH MARTIN
51 granted patents·17 pending applications·387 citations·filing 2004–2023
98Inventor score
Top patents by PatentIndex Score
68 records- 0197US11702424B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2020·Granted Jul 18, 2023·4 cites·8 claims
- 0297US8933236B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Jan 13, 2015·50 cites·32 claims
- 0396US10815229B1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Oct 27, 2020·4 cites·29 claims
- 0495US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0595US9879022B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2016·Granted Jan 30, 2018·19 cites·22 claims
- 0695US9458168B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2015·Granted Oct 4, 2016·17 cites·44 claims
- 0795US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0894US8895544B2IndazolesPFIZER LTD·Filed 2013·Granted Nov 25, 2014·43 cites·18 claims
- 0992US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 1092US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 1192US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 1292US8575336B2IndazolesCOE JOTHAM WADSWORTH·Filed 2012·Granted Nov 5, 2013·41 cites·13 claims
- 1392US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 1491US10793579B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2019·Granted Oct 6, 2020·3 cites·8 claims
- 1591US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 1691US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 1791US9771376B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 26, 2017·7 cites·19 claims
- 1891US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 1990US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 2089US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 2189US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 2289US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 2388US9518052B2Pyrazolopyridines and pyrazolopyrimidinesPFIZER·Filed 2015·Granted Dec 13, 2016·8 cites·12 claims
- 2487US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 2587US9493429B2Substituted benzoxazoles and methods of use thereofGENENTECH INC·Filed 2014·Granted Nov 15, 2016·10 cites·24 claims
- 2686US10329302B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2018·Granted Jun 25, 2019·3 cites·2 claims
- 2785US12202836B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2023·Granted Jan 21, 2025·0 cites·14 claims
- 2885US10174000B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2016·Granted Jan 8, 2019·5 cites·10 claims
- 2985US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 3084US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 3183US9550775B2Substituted triazolopyridines and methods of use thereofGENENTECH INC·Filed 2014·Granted Jan 24, 2017·7 cites·26 claims
- 3282US10981905B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·1 cites·54 claims
- 3382US10766858B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2017·Granted Sep 8, 2020·1 cites·19 claims
- 3481US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 3581US10022376B2Pyrazolopyridines and pyrazolopyrimidinesPFIZER·Filed 2016·Granted Jul 17, 2018·3 cites·9 claims
- 3679US10316018B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2018·Granted Jun 11, 2019·2 cites·4 claims
- 3779US7582772B2Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as CPLA2 inhibitorsWYETH CORP·Filed 2005·Granted Sep 1, 2009·3 cites·37 claims
- 3876US10787446B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 29, 2020·1 cites·26 claims
- 3976US10526285B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 7, 2020·1 cites·17 claims
- 4075US10752623B2Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitorsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·1 cites·38 claims
- 4172US7781427B2Process for preparing quinoline compounds and products obtained therefromWYETH LLC·Filed 2005·Granted Aug 24, 2010·1 cites·54 claims
- 4270US11149002B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 19, 2021·0 cites·13 claims
- 4370US10071957B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Sep 11, 2018·1 cites·2 claims
- 4469US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4567US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4665US7342119B2Process for the synthesis of a CPLA2 inhibitorWYETH CORP·Filed 2004·Granted Mar 11, 2008·2 cites·22 claims
- 4764US11639351B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2021·Granted May 2, 2023·0 cites·18 claims
- 4864US7842837B2Process for the synthesis of C-2, C-3 substituted N-alkylated indoles useful as cPLA2 inhibitorsWYETH LLC·Filed 2009·Granted Nov 30, 2010·0 cites·4 claims
- 4964US2015224071A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 5062US2024101531A1Pyridinamine derivatives and their use as potassium channel modulatorsXENON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →